Fuldem YILDIRIM DÖNMEZ, Ahmet Muhtesem AGİLDERE, Feride RAHATLI KURAL, Kemal Murat HABERAL

Use of susceptibility weighted imaging to assess hemorrhage in brain metastases

Aim: Detection of intratumoral hemorrhage in metastatic lesions leads to determination of treatment options.We evaluated the diagnostic value of precontrast SWI for the detection of blood products in brain metastases by comparing SWI to conventional sequences.Material and Methods: Brain magnetic resonance imaging (MRI) sequences were acquired between April 2014 and November2015 from 21 patients with brain metastases, and were retrospectively evaluated for the presence of hemorrhagic elements. All examinations were performed on a 1.5 Tesla Siemens scanner. Our routine protocol included axial T1-weighted (T1W), T2-weighted (T2W), and FLAIR sequences, coronal and sagittal T2W sequences, post gadolinium axial and sagittal T1W sequences, and a coronal FSE T1W sequence, in addition to the precontrast SWI sequence.Results: Seventy-one intraparenchymal metastatic lesions (range: 0.5–3.5 cm) were detected. No hemorrhages were detected in 25 lesions (35.2%), while in 12 lesions (16.9%) hemorrhage was detected by SWI and T1 and/or T2 weighted images. In 34 lesions (47.88%) hemorrhage was detected only on the SWI sequence, and it was not seen on the conventional sequences.Conclusion: SWI provided better information for the evaluation of intratumoral hemorrhage than T1W and T2W sequencesof the inner structure of metastases. T1W and T2W images did not provide sufficient detection of hemorrhagic elements; SWI is therefore needed to detect intratumoral hemorrhage, and the sequence should be added to the protocol to allow better characterization.

PDF

___

Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field highresolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol 2009; 30(7):1402-8.
Roelcke U, Boxheimer L, Fathi AR, Schwyzer L, Ortega M, Berberat J, et al. Cortical hemosiderin is associated with seizures in patients with newly diagnosed malignant brain tumors. J Neurooncol 2013;115(3):463-8.
Zhang W, Ma XX, Ji YM, Kang XS, Li CF. Haemorrhage detection in brain metastases of lung cancer patients using magnetic resonance imaging. J Int Med Res 2009;37(4):1139-44.
Berberat J, Grobholz R, Boxheimer L, Rogers S, Remonda L, Roelcke U. Differentiation between calcification and hemorrhage in brain tumors using susceptibilityweighted imaging: a pilot study. AJR Am J Roentgenol 2014;202(4):847-50.
Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neurooncology working group. J Clin Oncol 2010;28(11):1963-72.
Robinson RJ, Bhuta S. Susceptibility-weighted imaging of the brain: current utility and potential applications. J Neuroimaging 2011;21(4):189-204.
Kondziolka D, Bernstein M, Resch L, Tator CH, Fleming JF, Vanderlinden RG, et al. Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg 1987;67(6):852-7.
Hamilton R, Krauze M, Romkes M, Omolo B, Konstantinopoulos P, Reinhart T, et al. Pathologic and gene expression features of metastatic melanomas to the brain. Cancer 2013;119(15):2737-46.
Franceschi AM, Moschos SJ, Anders CK, Glaubiger S, Collichio FA, Lee CB, et al. Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma. J Comput Assist Tomogr 2016;40(5):803-5.
Pinker K, Noebauer-Huhmann IM, Stavrou I, Hoeftberger R, Szomolanyi P, Karanikas G, et al. High- resolution contrastenhanced susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positronemission tomography and histopathologic findings. AJNR Am J Neuroradiol 2007;28(7):1280-6.
Pinker K, Noebauer-Huhmann IM, Stavrou I, Hoeftberger R, Szomolanyi P, Weber M, et al. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors. Neuroradiology 2008;50(1):9-16.
Gomori JM, Grossman RI, Yu-Ip C, Asakura T. NMR relaxation times of blood: dependence on field strength, oxidation state, and cell integrity. J Comput Assist Tomogr 1987;11(4):684-90.
Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26(4):736-42.
Hori M, Ishigame K, Kabasawa H, Kumagai H, Ikenaga S, Shiraga N, et al. Precontrast and postcontrast susceptibilityweighted imaging in the assessment of intracranial brain neoplasms at 1.5 T. Jpn J Radiol 2010;28(4):299-304.
Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006;24(1):41-51.
Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204(1):272-7.